CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Regulation FD disclosure
- 4 Open-market buy CEO bought 10,730 shares at $2.33 ($25,001)
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K Event Results of operations · Regulation FD disclosure
Page 24 of 82 · 1,637 filings